How to Buy Biomarin Pharmaceutical Stock
Biomarin Pharmaceutical Inc
BioMarin Pharmaceutical Inc. specializes in creating and bringing to market treatments for individuals suffering from severe and often fatal rare disorders and other critical medical conditions.
Biomarin Pharmaceutical stock last closed at $56.03, down 0.16% from the previous day, and has increased 8.08% in one year. It has overperformed other stocks in the Biotechnology industry by 1.04 percentage points. Biomarin Pharmaceutical stock is currently +13.75% from its 52-week low of $49.26, and -21.06% from its 52-week high of $70.98.
At the moment, there are 193.69M shares of BMRN outstanding. The market value of BMRN is $10.85B. In the last 24 hours, 2.73M BMRN shares were traded.
How to Buy Biomarin Pharmaceutical Stock
Not sure how to invest in Biomarin Pharmaceutical stock? Here's how.
- Choose where to buy Biomarin Pharmaceutical stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you determine where to buy Biomarin Pharmaceutical stock.
- Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Put funds into your investment account: Select your payment method and add your details.
- Research Biomarin Pharmaceutical stock: The Biomarin Pharmaceutical ticker symbol is BMRN. Is Biomarin Pharmaceutical stock a good investment? Should you buy shares of BMRN? How do BMRN's underlying business fundamentals look? Do top analysts think Biomarin Pharmaceutical is a good buy? Why has BMRN's stock price moved recently? (Hint: Our stock research tools can help you decide if BMRN is a good stock to buy).
- Make your BMRN buy order: Decide if you will purchase BMRN shares at the current market price or use a limit order to buy BMRN shares at a given price.
- Get notifications regarding your BMRN investment: Create a watchlist to important notifications about your new investment in Biomarin Pharmaceutical shares.
Step 1: Choose where to buy Biomarin Pharmaceutical stock
You need an online brokerage account in order to access the NASDAQ market and buy BMRN stock.
Our recommended brokerage: eToro
We believe that eToro is the best stock brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to global markets: From Technology to Healthcare, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've selected your brokerage, you'll need to fill out some personal info so you are able to buy BMRN stock today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to open a new brokerage account.
- Send your information by pressing the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you've created your account on apps for stock market, your next step is to transfer the money for your investment:
Check out the walkthrough below if you need help transferring money into your investment account.
Step 4: Research Biomarin Pharmaceutical stock
Once you have decided on the best place to buy Biomarin Pharmaceutical stock, it's absolutely critical to research their stock prior to investing, so you actually understand the risk as well as the upside.
Biomarin Pharmaceutical Metrics
Biomarin Pharmaceutical Fundamentals
WallStreetZen was built to help part-time investors perform more accurate fundamental analysis quickly.
You can view all of the due diligence checks on BMRN's stock page.
Is BMRN stock undervalued or overvalued?
You can use many financial metrics, analyses, models, and charts to gauge BMRN's intrinsic value.
Using relative valuations ratios:
- BMRN may be undervalued based on its P/B ratio of 1.73x, relative to Biotechnology industry P/B ratio of 5.2x
You can access additional valuation research on BMRN's stock here.
BMRN Financial Overview
Pros:
- There are more short-term assets than short-term liabilities on the BMRN balance sheet.
- There are more short-term assets than long-term liabilities on the BMRN balance sheet.
Cons:
- BMRN's operating cash flow of $676.62M allows it to safely service it's debt of $4.17B.
- BMRN profit margin has gone down from 16.8% to -0.5% in the past year.
- BMRN has a relatively high debt to equity ratio of 0.85.
- Total BMRN debt is higher than 5 years ago, relative to shareholder equity.
- BMRN earnings of $180.32M is not enough to cover its interest payments.
Is Biomarin Pharmaceutical stock a Buy, Hold, or Sell, according to analysts?
Out of 16 Equities analysts who track BMRN, the consensus analyst rating on Biomarin Pharmaceutical is a Strong Buy
It's important to note that analyst ratings are not recommendations, nor are they investment advice.
Most Recent BMRN Analyst Upgrades/Downgrades
Paul Matteis, a bottom 12% analyst from Stifel Nicolaus maintains BMRN with a hold rating and lowers their BMRN price target from $70.00 to $66.00, on Nov 3, 2026.
Olivia Brayer Saunders, a bottom 7% analyst from Cantor Fitzgerald reiterates BMRN with a strong buy rating and maintains their BMRN price target from $86.00 to $86.00, on Oct 20, 2026.
Joon Lee, a top 2% analyst from UBS assumes BMRN with a strong buy rating and lowers their BMRN price target from $114.00 to $88.00, on Oct 15, 2026.
Eliana Merle, a top 15% analyst from Barclays maintains BMRN with a strong buy rating and raises their BMRN price target from $111.00 to $114.00, on Oct 14, 2026.
Barclays's Eliana Merle raised their price target on Biomarin Pharmaceutical (NASDAQ: BMRN) by 2.7% from $111 to $114 on 2026/10/14. The analyst maintained their Strong Buy rating on the stock.
Biomarin Pharmaceutical is expected to report its Q3 2026 earnings on 2026/10/26.
Noting that company management "sounds optimistic" about Voxzogo's resilience, Merle called FY 2027 a pivotal year for the company's pipeline.
Allison Bratzel, a top 13% analyst from Piper Sandler maintains BMRN with a strong buy rating and raises their BMRN price target from $88.00 to $90.00, on Sep 1, 2026.
You can dig deeper into what analysts are saying on the Biomarin Pharmaceutical stock forecast page.
Metrics for Advanced BMRN Traders
BMRN Growth Metrics
Last year, BMRN revenue was $3.66B. In the past five year, BMRN's revenue has grown by 14.61% per year. This was slower than the Biotechnology industry average of 25.75%.
Dig into BMRN's earnings and revenue performance here.
What are BMRN insiders up to?
Over the last year, executives and large shareholders at BMRN have sold more shares than they have bought.
Gregory R. Friberg, EVP;CXO of BMRN, was the latest BMRN insider to sell. They sold $245,160.00 worth of BMRN shares on Sep 30, 2026.
Research more about who owns BMRN shares here.
Can I get consistent income from BMRN stock?
No, Biomarin Pharmaceutical doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Make your BMRN buy order
There are two main order types:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are mostly the easiest way to buy. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a given dollar amount limit, use a limit order.
Click the Open Trade button and eToro will place your order.
If you require more help buying stocks on eToro, watch the how to video below:
Step 6: Get notifications regarding your BMRN investment
Now that you own some shares in BMRN, you'll want to keep up with your stock purchase.
Make a watchlist to get alerted to the latest events about your BMRN stock.
BMRN Feed
How to Buy Stock in Biomarin Pharmaceutical
To reiterate, here are the 6 steps to buy Biomarin Pharmaceutical stock:
- Choose where to buy Biomarin Pharmaceutical stock
- Open your brokerage account
- Put funds into your investment account
- Research Biomarin Pharmaceutical stock
- Make your BMRN buy order
- Get notifications regarding your BMRN investment
If you are looking for a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get notifications regarding your investment in Biomarin Pharmaceutical, add BMRN to your watchlist below.
Other Stock Buying Guides You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.